a:3:{s:6:"_token";s:40:"vicvQjYC216Q7IBWoYMtLxI91s4hkDQLwi7UOpRS";s:9:"_previous";a:1:{s:3:"url";s:212:"https://www.pharmafocusasia.com/pressreleases/gannexs-strategic-partner-sagimet-biosciences-announces-positive-topline-results-from-phase-2b-fascinate-2-clinical-trial-of-denifanstat-in-biopsy-confirmed-f2f3-nash";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}